We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 13 for:    cervical cancer and LOT
Previous Study | Return to List | Next Study

Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix

This study has been terminated.
(slow accrual)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00204997
First Posted: September 20, 2005
Last Update Posted: October 2, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Wisconsin, Madison
  Purpose
The purpose of this study is to evaluate the feasibility, safety and efficacy of laparoscopic ovarian transposition in women less than 40 years of age with locally advanced cervical squamous cell carcinoma

Condition Intervention
Cervical Cancer Procedure: Laparoscopic ovarian transposition

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Preservation of Ovarian Function Via Laparoscopic Transposition in Patients With Locally Advanced Squamous Cell Carcinoma of the Cervix

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Menopause [ Time Frame: 6 months ]

Estimated Enrollment: 10
Study Start Date: September 2002
Study Completion Date: February 2008
Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Laparoscopic Ovarian Transposition
Procedure: Laparoscopic ovarian transposition
Laparoscopic ovarian transposition

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Newly diagnosed Stages iB-iiiB squamous cell carcinoma of the cervix

Exclusion Criteria:

  • Evidence of ovarian involvement on MRI
  • Evidence of uterine involvement on MRI
  • Evidence of distant mets on MRI
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00204997


Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: David M Kushner, MD University of Wisconsin, Madison
  More Information

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00204997     History of Changes
Other Study ID Numbers: CO 02702
2002-255
First Submitted: September 13, 2005
First Posted: September 20, 2005
Last Update Posted: October 2, 2015
Last Verified: June 2008

Keywords provided by University of Wisconsin, Madison:
Cervical Cancer
Squamous Cell
Laparoscopy
Ovarian Function

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Squamous Cell
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Uterine Cervical Diseases
Carcinoma, Squamous Cell
Carcinoma
Uterine Diseases
Genital Diseases, Female